Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer. (Q54317292)
Jump to navigation
Jump to search
scientific article published on 6 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer. |
scientific article published on 6 October 2014 |
Statements
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer. (English)
1 reference
1 reference
Binghe Xu
1 reference
Wael Harb
1 reference
Rebecca Moroose
1 reference
Timothy Pluard
1 reference
Corinne Kiger
1 reference
Caroline Germa
1 reference
Kongming Wang
1 reference
José Baselga
1 reference
Sung-Bae Kim
1 reference
6 October 2014
1 reference
32
1 reference
32
1 reference
3626-3633
1 reference
Identifiers
1 reference